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Abstract
Background: The clinical presentation of common symptoms during depressive episodes in bipolar disorder (BD)
and major depressive disorder (MDD) poses challenges for accurate diagnosis. Disorder-specific neuroanatomical
features may aid the development of reliable discrimination between these two clinical conditions.
Methods: For our sample of 16 BD patients, 19 MDD patients and 29 healthy volunteers, we adopted vertex-wise
cortical based brain imaging techniques to examine cortical thickness and surface area, two components of cortical
volume with distinct genetic determinants. Based on specific characteristics of neuroanatomical features, we then
used support vector machine (SVM) algorithm to discriminate between patients with BD and MDD.
Results: Compared to MDD patients, BD patients showed significantly larger cortical surface area in the left
bankssts, precuneus, precentral, inferior parietal, superior parietal and the right middle temporal gyri. In addition,
larger volumes of subcortical regions were found in BD patients. In SVM discriminative analyses, the overall accuracy
was 74.3 %, with a sensitivity of 62.5 % and a specificity of 84.2 % (p = 0.028). Compared to controls, larger surface
area in the temporo-parietal regions were observed in BD patients, and thinner cortices in fronto-temporal regions
were observed in MDD patients, especially in the medial orbito-frontal area.
Conclusions: These findings have demonstrated distinct spatially distributed variations in cortical thickness and
surface area in patients with BD and MDD, suggesting potentially varying etiological and neuropathological
processes in these two conditions. The employment of multimodal classification on disorder-specific biological
features has shed light to the development of potential classification tools that could aid diagnostic decisions.
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Background
Whether bipolar disorder (BD) and major depressive dis-
order (MDD) are two discrete diagnostic entities or they
belong to the same disorder spectrum has received con-
siderable research interest during the past decade. These
two psychiatric conditions exhibit similar severe depres-
sive symptoms, but show no difference in the duration
of affective episodes during the course of illness [1].
However, in clinical practice, reliably distinguishing be-
tween BD and MDD is paramount for clinicians to avoid
risks of misdiagnosis and inappropriate medication treat-
ments. Although BD consists of alternating episodes of
depression and mania/hypomania, the early presentation
of depressive symptoms in these patients often increases
the chances of them being misdiagnosed as MDD during
the early onset stage. In addition, clinical studies reported
higher prevalence of depressive relative to manic/
hypomanic symptoms in BD. The presence of subthreshold
manic symptoms during a depressive episode also made the
distinction between BD and MDD difficult [2]. Thus, it
poses a major challenge for clinicians to reliably diagnose
BD and MDD, particularly when recurring episodes of
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depression are the primary common affective symptoms in
both conditions [3].
Emerging evidence suggests that BD and MDD might
have distinct biological features, despite both conditions
showing similarities in depressive behavioral presenta-
tions. Clinically, compared to patients with MDD, pa-
tients with BD have been found to have earlier and acute
onset, and more total episodes [4]. Biologically, evidence
from genotypic [5] and endophenotypic [6] studies have
shown different biological characteristics between BD
and MDD. Neuroimaging studies revealed that com-
pared to MDD, BD patients demonstrate more wide-
spread white matter abnormalities, grey matter volume
reductions, and different aberrant functional connectiv-
ity in the neural circuitries responsible for emotion regu-
lation, attentional control [7] and reward-processing [8].
Zhao et al. suggested in a meta-analysis abnormal inhib-
ition associated with the cerebello-thalamo-prefrontal
circuitry in psychiatric conditions, including MDD and
BD [7]. Also, recent functional studies showed that the
mania/hypomania symptoms in BD were associated with
elevated reward-related activation in dopamine-rich
brain regions [8, 9], while blunted striatal signaling
might constitute a risk factor for MDD [10]. However,
few disorder-specific neuroanatomical features have yet
been identified in BD and MDD, and their underlying
neurobiological mechanisms remain unclear.
In this study, we aimed to identify these features dis-
tinguishing between BD and MDD by adopting the
cortical-surface based technique to examine two virtually
orthogonal components of cortical volume with distinct
genetic determinants [11], namely, cortical thickness and
surface area. Cortical thickness has been associated pri-
marily with intermediate progenitor cells [12], which
function as neurogenic transient amplifying cells to form
ontogenetic columns during cerebral cortical develop-
ments. Surface area, on the other hand, has been associ-
ated with the proliferation of radial unit progenitors,
which consist of neuroepithelial cells and radial glial
cells [13], and functionally involve in the mechanisms of
arborization, pruning within grey matter [14], and varying
myelination at the grey/white matter interface [15]. Given
that cortical thickness and surface area have varying gen-
etic influences, investigating them separately would allow
understanding of distinct neurobiological mechanisms
underlying disorder-specific conditions. To our know-
ledge, only a few imaging studies have directly compared
BD and MDD [16, 17], and most of these have focused on
cortical thickness. For instance, Lan and colleagues re-
ported that relative to healthy controls, thinner caudal
middle frontal cortex was exclusively found in patients
with BD, but not MDD [16]. Other studies examined cor-
tical thickness separately in isolation of the disorders. Han
and colleagues examined cortical thickness, together with
cortical and subcortical volumes and white matter integ-
rity in patients with first episode of MDD. Cortical volume
reductions have been reported in caudal anterior cingu-
late, caudal frontal gyrus and medial orbitofrontal gyrus in
MDD patients [18]. However, in these studies, measures
of surface area were not examined. With BD and MDD
sharing similar clinical presentations but may have poten-
tially distinct neuroanatomical features, it would be neces-
sary to compare the surface area and the subcortical
regions in the dopamine-rich mesocorticolimbic pathways
that have been consistently found to be abnormal in
patients with BD and MDD [19–22]. These include thal-
amus, caudate nucleus, putamen, nucleus accumbens,
hippocampus and amygdala.
Recently, machine-learning based discriminating clas-
sifications have been employed to distinguish between
patients with different mental disorders utilizing individ-
ual structural and functional brain images. Such sophis-
ticated statistical learning models analyze imaging data
by recognizing specific patterns, allowing the distinction
of disorders with application to aid diagnostic decisions
[23, 24]. For instance, support vector machine-based
(SVM) algorithms have been used experimentally to
classify patients with Alzheimer’s disease [25–27], aut-
ism [28], schizophrenia and depression [29–31]. In a
pilot study that studied patients with affective disor-
ders, Grotegerd and colleagues successfully discrimi-
nated between patients with unipolar and bipolar
depressive status by pattern-classifying their functional
images [29]. This neuroimaging-aided approach allows
the differentiation of diagnoses based on disorder-specific
biological features. Similar but improved automatic classi-
fication using multimodal brain structural features is
adopted in this study.
In this study, the primary analyses involved whole
brain comparisons on cerebral cortical thickness and
surface area between patients with BD and MDD, as
well as with a group of healthy volunteers in an ex-
ploratory manner. We then examined the volumes of
subcortical regions-of-interest (ROI), which have been
found to be associated with BD and MDD. Based on
the ROI morphological features identified from pri-
mary analyses, SVM discriminating classification was
subsequently computed to distinguish between pa-
tients with BD and MDD. Applying parameters of
specific cortical and subcortical features would im-
prove the overall accuracy of the discriminating clas-
sification. We hypothesized that BD and MDD would
have shared but also distinct neuroanatomical fea-
tures, in terms of cortical thickness, surface area and
subcortical volumes especially in the regions involved
in the mesocorticolimbic pathways. Multimodal classi-
fication on these disorder-specific features would aid
the discrimination between BD and MDD.
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Methods
Participants
A total of 16 patients diagnosed with BD (mixed types of
BD-I, BD-IIs, and BD-NOS; 6 males, mean age = 26.3 years,
SD = 7.9 years) and 19 patients diagnosed with MDD (8
males, mean age = 30.0 years, SD = 8.9 years) were recruited
from local hospitals in Beijing, China (Institute of Mental
Health, The Third Affiliated Hospital of Beijing Chinese
Medicine University, and Beijing Hui-Long-Guan Hospital).
Patients were diagnosed by experienced psychiatrists (MQ,
YTM, ZRW) according to DSM-IV criteria [32]. For com-
parison purpose, a group of 29 healthy controls (HC, 11
males, mean age = 27.1 years, SD = 8.4 years) were also re-
cruited from communities in Beijng. They were demo-
graphically (handedness, age, gender, educational level and
IQ) well matched (see Table 1). All participants in this study
were right-handed, as measured by the Annett Handedness
Scale [33]. Their IQ scores were estimated using the short
form of the Chinese version of the Wechsler Adult
Intelligence Scale-Revised (WAIS-R) [34]. The IQ estimates
and handedness were assessed by trained researchers (QZ,
ZL). Exclusion criteria for both clinical groups included
patients with psychiatric comorbidities [18]; a history of
psychotic symptoms; a history of neurological disorder; a
lifetime prevalence of substance abuse; an IQ estimate
lower than 70; and not being able to be scanned by MRI.
Exclusion criteria for healthy controls were similar to the
clinical groups, with the addition of no family history of
neuropsychiatric or neurological disorders. This study
received ethical approvals from the three local hospi-
tals (Institute of Mental Health; The Third Affiliated
Hospital of Beijing Chinese Medicine University; Beijing
Hui-Long-Guan Hospital) and the Institute of Psychology,
Chinese Academy of Sciences. Written informed consent
was obtained from each participant before the study.
Medication and clinical characteristics
Medication histories of the two clinical groups are
summarized in Table 1. The doses of antipsychotics in
medication were transformed into Chlorpromazine
equivalent (CPZ) [35, 36]. In the MDD group, eight of
19 patients (42.1 %) were medication-free at the time of
assessment. The remaining 11 patients were taking antide-
pressants, including Citalopram, Mirtazapine, Venlafaxine,
Table 1 Demographic and clinical characteristics
BD (n = 16) MDD (n = 19) HC (n = 29) F/χ2/t-scores p-value
Male % (male/female) 37.5 % (6/10) 42.1 % (8/11) 37.9 % (11/18) χ2 = 0.11 0.95
Right-handed % 100 100 100 F(2) = 0.00 1.00
Age (in years) 26.3 (7.9) 30.0 (8.9) 27.1 (8.4) F(2) = 1.02 0.37
Education (in years) 15.1 (1.8) 14.4 (3.2) 14.9 (2.5) F(2) = 0.42 0.66
IQ estimates 116.9 (16.1) 116.7 (13.1) 120.4 (12.7) F(2) = 0.54 0.59
Intracranial Volume (ICV, cm3) 1295 (207) 1439 (195) 1372 (201) F(2) = 2.24 0.12
Medication History
Untreated (N) 5 8 / / /
Antidepressants (N) 5 11 / / /
Antipsychotics (N) 8 2 / / /
CPZ (mg) 226.2 (327.4) 38.3 (40.1) / / /
Atypical (N) 8 1 / / /
Typical (N) 0 1 / / /
Trihexyphenidyl (N) 1 0 / / /
Antianxiety (N) 2 3 / / /
Lithium (N) 2 0 / / /
Valproate (N) 2 0 / / /
Lithium + Valproate (N) 1 0 / / /
Clinical Information
Duration of illness (in years)* 5.2 (4.8) 4.9 (3.5) / t = -0.23 0.82
HAMD-17* 9.9 (4.5) 11.1 (4.3) / t = 0.77 0.45
YMRS* 6.40 (6.9) 2.2 (2.6) / t = -2.35 0.03
Abbreviations: MDD Major Depressive Disorder, BD Bipolar Disorder, HC Health Controls, YMRS Young Mania Rating Scale, HAMD-17 Hamilton rating scale for
Depression-17 items, N number of patients
*p-values were generated from comparisons between the BD and MDD groups (t-tests, two-tailed)
Chi-squared test was used in gender. One-way analyses of variance (ANOVA) were used in age, IQ estimates, handedness, education and ICV
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Sertraline, Paroxetine, Fluoxetine, and Duloxetine
hydrochloride. Among the 11 medicated patients, two
of them were also taking antipsychotics (Flupentixol
dihydrochloride, CPZ = 10 mg; and Aripiprazole, CPZ =
67 mg); three of them were taking anti-anxiety medicines
(including Clonazepam, Buspirone, and Lorazepam). In the
BD group, five of 16 patients (31.3 %) were medication-free
at the time of assessment. Among the 11 medicated pa-
tients, five of them were taking antidepressants (including
Venlafaxine, Sertraline, Fluoxetine, Fluvoxamine, Duloxe-
tine hydrochloride); eight of them were taking atypical anti-
psychotics (including Olanzapine, Quetiapine, Risperidone,
Aripiprazole, mean CPZ = 226.2 mg, SD = 327.4 mg); one
of them was taking Trihexyphenidyl; five of them were tak-
ing mood stabilizers (Lithium and Valproate); and two of
them were taking anti-anxiety medicines (Clonazepam and
Lorazepam).
No group difference was found for duration of illness
(p >0.05) between patients with BD and MDD. In both
clinical groups, major depressive symptoms and manic
symptoms were assessed by experienced psychiatrists
(MQ, YTM, ZRW) using the 17-item Hamilton Rating
Scale for Depression (HAMD) [37] and the Young
Mania Rating Scale (YMRS) [38]. No difference was
found between patients with BD and MDD in the 17-
item HAMD total score (t = 0.77, p = 0.45). However, as
expected, lower YMRS total score (t = -2.35, p = 0.03)
was observed in the MDD group than the BD group.
MRI acquisitions and preprocessing
High-resolution T1-weighted images from all partici-
pants were acquired on a 3-Tesla scanner (Siemens 3 T-
Trio A Tim, Erlangen, Germany) at the MRI Center of
Beijing 306 Hospital. Before image collection, a pre-scan
lasting one minute and 10 s was taken and inspected by
clinical radiologists to exclude individuals with structural
brain abnormalities. The scanning parameters of the T1-
weighted images were as follows: slice thickness = 1 mm,
TE = 3.01 ms, TR = 2300 ms, 176 slices in sagittal plane,
field of view (FOV) = 256 mm, voxel size = 1 x 1 x
1 mm3, bandwidth = 240 Hz/pixel, duration = 6 min 56 s.
All participants were asked to close their eyes and re-
main motionless during data collection.
Cortical reconstruction and subcortical volumetric seg-
mentation were performed using the FreeSurfer imaging
analysis suite (v5.1.0, http://surfer.nmr.mgh.harvard.edu/)
[39]. Details of this pipeline are fully described on its web-
page. Briefly, the T1-weighted images were firstly regis-
tered to the Talairach space of each participant’s brain
with the skulls stripped. Images were then segmented into
white/grey matter (WM/GM) tissues based on local and
neighbouring intensities. The cortical surface of each
hemisphere was inflated to an average spherical surface to
locate both the grey matter (pial) surface and the
WM/GM boundary. Preprocessed images were visu-
ally inspected (by GF and YD) to ensure the recon-
struction and segmentation qualities. Any topological
defects were excluded from the subsequent analyses
but no data had to be excluded at this point. At the
cortical level, cortical thickness was measured as the
shortest distance between the pial surface and the
GM/WM boundary at each point across the cortical
mantle. Surface area was measured as the area of a
vertex on the pial surface, calculated as the average of
the tessellation areas touching that vertex. In addition,
the cerebral cortex of each participant was automatic-
ally parcellated into 70 regions according to the
Desikan-Killiany cortical atlas [40], with their mean cor-
tical thickness and surface area calculated for the ROI
analysis. Before group-level statistical analyses, individual
cortical surface maps were smoothed with a Gaussian
25 mm full-width-at-half-maximum (FWHM) kernel
when accounting for the sample size. At the subcortical
level, volumes of a series of subcortical structures were ex-
tracted using the automated segmentation function in
FreeSurfer [41] for the ROI analysis. Total intracranial vol-
ume (ICV) of each participant was also extracted.
Vertex-wise group comparison on cortical measures
Whole brain analyses of cortical thickness and surface
area were performed pairwise between each two groups of
participants (viz., BD vs MDD, HC vs BD, HC vs MDD)
using general linear models (GLM) in FreeSurfer’s QDEC
(Query, Design, Estimate, Contrast) operation, after co-
varying for ICV, age and IQ estimates. In an exploratory
manner, the significant threshold was set at p < 0.01 un-
corrected (two-tailed). To minimize Type I error, only
clusters with significant number of vertices greater than
200 were reported [42]. Significant clusters were mapped
to the Desikan-Killiany cortical atlas [40] based on the
structures of gyrus and sulcus. Group difference maps
were constructed in QDEC based on –log10 (p-value).
Region-of-Interest (ROI) analyses
ROI analyses were performed between the BD group
and the MDD group. At the cortical level, significant
clusters from the BD-MDD whole brain comparison
would be defined as ROI(s). At the subcortical level,
bilateral thalamus, caudate nucleus, putamen, hippo-
campus, amygdala and nucleus accumbens were de-
fined as ROIs. To control for individual variations of
ICV, age and IQ estimate, a ratio of each ROI was cal-
culated [ratio = ROI mean value/(ICV * age * IQ esti-
mate)]. Two sample t-tests were performed on the ROI
ratios, with the false discovery rate (FDR) corrected for
multiple comparisons.
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SVM classification
Using the ROI morphological features as input data, an
exploratory SVM was applied to classify patients with BD
and patients with MDD. SVM is a supervised multivariate
classification algorithm based on pattern recognition. In
brief, it separates the input data into different classes
(i.e., patients with BD and MDD) by identifying an optimal
separating hyperplane (OSH) or named decision bound-
ary. Initially the algorithm is trained on a subset of train-
ing data to find a hyperplane that best separates the input
data space according to their known class labels (i.e., pa-
tients’ group memberships, -1 =MDD and 1 = BD). After
the hyperplane is built by a set of support vectors, a subset
of test data are then classified using the predicted values
to determine which side of the hyperplane they should
locate. Given that the input data of the present study are
already dimensionally reduced ROI features, a non-linear
algorithm was chosen with a radial basis function kernel.
Parameters C and gamma, which controls a tradeoff be-
tween allowed training errors and misclassifications, and
the width of the radial basis function, were tuned using a
10-fold cross-validation approach. The optimized parame-
ters that provide the best accuracy would be selected for
the final model.
In the present study, the classifier’s performance is eval-
uated using the common leave-one-out-each-group cross-
validation approach. This validation procedure provides
robust parameter estimates particularly for smaller sam-
ples [22]. In each trial observation, one patient per group
was left out from the data to train the classifier, but then
used to determine the detection rate of this trained classi-
fier (testing). The procedure was repeated until every par-
ticipant had been used for testing a classifier. The overall
accuracy of the classifier was the averaged detection rate.
The sensitivity and specificity of the classifier were also
quantified. Specifically, sensitivity was calculated by the
number of true BD dividing by the total number of true
BD and those misclassified BD as MDD. Specificity was
calculated by the number of true MDD dividing by the
total number of true MDD and those misclassified MDD
as BD. To evaluate the probability of obtaining the overall
accuracy by chance, statistical significance was verified by
means of permutation tests [24]. We randomly assigned a
class label to each patient and repeated the same cross-
validation procedures for 1000 times. Then we counted
the total number of times that the detection rates from
the permutation tests were higher than or equal to the ac-
tual value obtained from the real test. A p-value for classi-
fication is derived from dividing this number by 1000. The
classifications were performed using R version 2.15.3 (R
Development Core Team 2013. The R Foundation for
Statistical Computing, Vienna, Austria. ISBN 3-900051-
07-0, URL http://www.R-project.org), with packages
“bootstrap”, “class”, and “e1071” implemented [43].
Results
Vertex-wise cortical thickness and surface area
No group difference in cortical thickness was observed
between patients with BD and patients with MDD, after
controlling for the possible individual variations in ICV,
age and IQ estimate. However, compared to the MDD
group, the BD group revealed larger surface area in left
bankssts, precentral, inferior parietal, superior parietal,
precuneus gyri, and the right middle temporal gyrus (see
Table 2 and Fig. 1).
Compared to the HC group, patients with BD had
thinner caudal anterior cingulate cortex (cACC) in the
right hemisphere, and reduced surface area in the left
posterior cingulate cortex (PCC). In contrast, patients
with BD had larger surface area than healthy controls in
the left postcentral, precuneus, supramarginal gyri, and
in the right superior temporal, insula and supramarginal
gyri (see Table 2 and Fig. 2).
Compared to the HC group, patients with MDD had
thinner cortices in the left medial orbito-frontal, parso-
percularis, middle temporal gyri, and reduced surface
area in the left rostral middle frontal gyrus. Larger sur-
face area in the left insula and the right supramarginal
gyrus were found in patients with MDD when compared
to HCs (see Table 2 and Fig. 3).
ROI results
Six ROIs were defined from the BD-MDD whole brain
group comparison at the cortical level. Similar to the
vertex-by-vertex comparison findings, the BD group had
larger surface areas than the MDD group in the left super-
ior parietal, left precuneus and the right middle temporal
gyri (p = 0.05, FDR corrected). Similar trends were also
found in the other three ROIs, despite not reaching statis-
tical significance (p < 0.1, FDR corrected, see Table 3).
At the subcortical level, the BD group was found to have
larger volumes in the ROIs than the MDD group, espe-
cially in the bilateral hippocampus, amygdala and nucleus
accumbens (p = 0.05, FDR corrected, see Table 3).
SVM classification results
Eighteen ROIs (i.e., 6 cortical and 12 subcortical regions)
listed in Table 3 were initially defined as discriminating
morphological features to classify between patients with
BD and MDD. Their ratio values were used in the ana-
lyses to control for the individual variations of ICV, age
and IQ estimate. The optimal parameters for the radial
basis function kernel were set to C = 100 and gamma =
0.0001 after tuning. In the final model, the overall accur-
acy of discriminating between patients with BD and
MDD was 74.3 %, with a sensitivity of 62.5 % and a spe-
cificity of 84.2 % (p = 0.028). This means that 26 out of
35 patients were correctly classified into the accurate
diagnostic category after taking into account the
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Fig. 1 Group differences in surface area between patients with BD and patients with MDD after controlling for age, IQ and the total intracranial
volume. Six clusters of larger surface area were observed in patients with BD, when compared to patients with MDD, including the left bankssts,
the left precentral gyrus, the left inferioparietal gyrus, the left superiorparietal gyrus, the left precuneus and the right middle temporal gyrus. Larger
surface area was colored in red. Clusters were overlaid on the average inflated image. Significance threshold was set to p < 0.01 (uncorrected). Clusters
with number of significant vertices greater than 200 were displayed. BD: Bipolar Disorder (n = 16); MDD: Major Depressive Disorder (n = 19)
Table 2 Significant differences in cortical thickness and surface area between patients with bipolar disorder, patients with major
depressive disorder and healthy controls after controlling for age, IQ and total intracranial volume
Measure Annotation log(p) Size (mm^2) Talairach coordinates Number of
verticesX Y Z
BD >MDD area.pial L bankssts 3.576 224.15 -58.5 -43.8 10.0 458
precentral 3.138 584.71 -51.4 3.2 18.7 1280
inferiorparietal 2.812 313.97 -42.2 -72.9 25.6 534
superiorparietal 2.670 107.18 -20.3 -68.9 35.3 208
precuneus 2.171 124.20 -10.4 -55.1 44.7 251
R middletemporal 3.419 812.33 62.4 -46.4 -0.5 1762
HC > BD area.pial L posteriorcingulate 2.658 175.49 -2.7 -24.4 26.5 486
thickness R caudalanteriorcingulate 2.182 105.74 3.4 9.5 25.8 259
HC < BD area.pial L postcentral -2.931 195.56 -44.9 -30.0 49.8 494
precuneus -2.528 196.41 -20.2 -65.8 24.6 375
supramarginal -2.340 160.41 -50.3 -48.5 37.0 374
R superiortemporal -3.884 702.71 44.3 -28.1 -4.7 1641
insula -2.684 153.36 39.8 -24.0 -1.9 464
supramarginal -2.204 127.56 52.7 -24.5 23.1 307
HC >MDD thickness L medialorbitofrontal 3.008 837.10 -12.5 43.8 0.7 1429
parsopercularis 2.894 670.07 -37.6 8.3 12.6 1926
middletemporal 2.504 292.69 -42.4 6.8 -35.0 340
area.pial L rostralmiddlefrontal 2.922 427.44 -39.4 20.9 30.0 832
HC <MDD area.pial L insula -2.870 170.71 -34.0 -0.2 14.7 482
R supramarginal -2.393 91.08 51.0 -24.6 21.8 215
p < 0.01, uncorrected, number of vertices > 200. L left hemisphere, R right hemisphere. HC Healthy Controls (n = 29), MDD Major Depressive Disorder (n = 19), BD
Bipolar Disorder (n = 16)
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Fig. 2 Group differences in cortical thickness and surface area between healthy controls and patients with BD after controlling for age, IQ and
the total intracranial volume. Six clusters of smaller surface area were observed in healthy controls, when compared to patients with BD, including the
left postcentral, precuneus, supramarginal, the right superiortemporal, insula and supramarginal gyri. Larger surface area of the left posterior cingulate
and thicker caudal anterior cingulate cortex were observed in healthy controls. Larger surface area/thickness was colored in red. Smaller surface
area/thickness was colored in blue. Clusters were overlaid on the average inflated image. Significance threshold was set to p < 0.01 (uncorrected).
Clusters with number of significant vertices greater than 200 were displayed. BD: Bipolar Disorder (n = 16); HC: Healthy Control (n = 29)
Fig. 3 Group differences in cortical thickness and surface area between healthy controls and patients with MDD after controlling for age, IQ
and the total intracranial volume. Three clusters of larger cortical thickness were observed in healthy controls than patients with MDD, including
the left medial orbitofrontal, parsopercularis and middle temporal gyri. When compared to patients with MDD, healthy controls had larger surface
area in the left rostral middle frontal gyrus, but smaller surface area in the left insula and the right supramaginal gyrus. Larger surface area/thickness
was colored in red. Smaller surface area/thickness was colored in blue. Clusters were overlaid on the average inflated image. Significance threshold
was set to p < 0.01 (uncorrected). Clusters with number of significant vertices greater than 200 were displayed. MDD: Major Depressive Disorder
(n = 19); HC: Healthy Control (n = 29)
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probability of randomness (see Fig. 4). Moreover, 10 out
of 16 BD patients were correctly classified, with the other
6 misclassified as MDD patients (sensitivity), and 16 out
of 19 MDD patients were successfully classified, with the
other 3 misclassified as BD patients (specificity).
Similar results were obtained, when we repeated the
analyses using only the ROIs that were found to be sig-
nificantly different between patients with BD and MDD
(i.e., 3 cortical and 6 subcortical ROIs in Table 3). With
these 9 ROIs as input features, the overall accuracy was
71.4 %, with a sensitivity of 56.3 % and a specificity of
84.2 % (p = 0.019, C = 100, gamma = 0.0001).
Discussion
We found significant differences in surface area and sub-
cortical volumes between BD and MDD, with application
to neuroanatomical classification between these two con-
ditions with adequate accuracy. Identifying disorder-
specific biological features of BD and MDD has important
clinical implications in facilitating efficient and specific
treatments. Given that BD and MDD share similar depres-
sive symptoms, patients with BD who have not yet devel-
oped a history of mania frequently got misdiagnosed as
MDD [17]. Moreover, inadequate treatments in patients
with BD may increase the risk of rapid cycling between
mood states [44]. Therefore, studying disorder-specific
biological features that reflect brain developmental path-
ways and mechanisms, such as cortical thickness and sur-
face area, would aid the development of reliable diagnostic
tools to distinguish between BD and MDD.
Table 3 Differences in regions-of-interest (ROIs) between patients with bipolar disorder and patients with major depressive disorder
after controlling for age, IQ and total intracranial volume
ROI df Mean in BD Mean in MDD t p p.adj (FDR)
Cortical (area.pial) L bankssts 32.09 2.80E-07 2.31E-07 1.73 0.09 0.09
L precentral 29.01 1.33E-06 1.11E-06 1.83 0.08 0.09
L inferiorparietal 32.28 1.32E-06 1.09E-06 1.91 0.07 0.09
L superiorparietal 28.98 1.53E-06 1.17E-06 2.45 0.02 0.05
L precuneus 28.98 1.10E-06 8.56E-07 2.41 0.02 0.05
R middletemporal 27.53 9.76E-07 7.59E-07 2.43 0.02 0.05
Subcortical (volume) L thalamus 25.72 1.99E-06 1.60E-06 1.95 0.06 0.08
L caudate nucleus 28.90 9.85E-07 8.13E-07 1.84 0.08 0.08
L putamen 26.15 1.70E-06 1.36E-06 1.99 0.06 0.08
L hippocampus 23.37 1.20E-06 9.15E-07 2.42 0.02 0.05
L amygdala 25.70 4.95E-07 3.83E-07 2.68 0.01 0.05
L nucleus accumbens 25.27 1.64E-07 1.17E-07 2.52 0.02 0.05
R thalamus 25.07 1.94E-06 1.60E-06 1.89 0.07 0.08
R caudate nucleus 27.58 1.01E-06 8.17E-07 1.89 0.07 0.08
R putamen 26.37 1.65E-06 1.31E-06 2.07 0.05 0.08
R hippocampus 24.94 1.24E-06 9.56E-07 2.57 0.02 0.05
R amygdala 27.23 5.03E-07 3.96E-07 2.44 0.02 0.05
R nucleus accumbens 28.10 1.84E-07 1.36E-07 2.47 0.02 0.05
A ratio of each ROI was calculated to control for the individual variations of ICV, age and IQ. Ratio ROI mean value/(ICV * age * IQ estimate), df degree of freedom,
p.adj (FDR) adjusted p-value, with false discovery rate corrected. BD Bipolar Disorder (n = 16), MDD Major Depressive Disorder (n = 19)
Fig. 4 Classification plots showing group allocation of patients with
BD and MDD
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Larger surface area was observed in patients with BD
in comparison to MDD in the left fronto-temporo-
parietal regions, as well as the right temporal lobe. How-
ever, no significant difference in cortical thickness was
observed between BD and MDD. This is in contrast to a
recent study reporting that patients with BD had thinner
cortices in the left inferior parietal gyrus, the right cau-
dal middle frontal gyrus and precuneus when compared
to patients with MDD [16]. This discrepancy could be
due to variations in intracranial volumes, which was
carefully controlled for in this study. Furthermore, com-
pared to HC, patients with BD had larger surface area in
the temporo-parietal regions, but thinner cortices and
reduced surface area in the cingulate cortices in both
hemispheres. However, patients with MDD revealed sig-
nificant reductions of cortical thickness in the left medial
orbitofrontal and parsopercularis gyri, when compared
to healthy controls. Despite certain discrepancies are
likely to be attributable to the heterogeneity of these dis-
orders, our findings are in line with other volumetric
studies showing that both conditions have abnormalities
in the anterior cingulate cortex, dorsolateral prefrontal
cortex and orbitofrontal cortex [19, 45]. In patients with
BD, reduced grey matter volumes in the prefrontal and
temporal lobes have been consistently reported, particu-
larly in the orbitofrontal gyrus, a region found to have
functional impact in affective processing and decision
making [46]. However, studies of grey matter volume
conflate the contributions of cortical thickness and
surface area as each of these two dimensions provide im-
portant neurobiological information on the basic struc-
tural elements in brain development. Therefore, by
delineating the measurements of volume into cortical
thickness and surface area, our findings aid the under-
standing of underlying neuropathological processes of
the cerebral cortex in patients with BD and MDD.
In cortical development, neurons within the cerebral
cortex are organized into ontogenetic columns [47]. Ac-
cording to the radial unit hypothesis [48], cells within a
column share a common origin and migrate to their lo-
cation within the cortex. Cortical thickness, which con-
tains the intermediate progenitor cells, reflects the
number of neurons produced within each column. How-
ever, the size of surface area reflecting proliferation of
radial unit progenitor cells is driven by the number of
ontogenetic columns [13]. In this study, reductions of
cortical thickness were found in the left medial orbito-
frontal cortex and parsopercularis (Brodmann area 44)
in patients with MDD as compared to healthy controls,
indicating a possibility of neuron number reductions in
these regions. Orbitofrontal cortex and parsopercularis
of the inferior frontal gyrus are brain regions involved in
emotional processing. Brain volume reduction in these
areas has been evidenced as one of characteristics in
MDD [49] and abnormalities in the orbitofrontal regions
were observed to be cytoarchitectionically distinct with
functional consequence with respect to mood regulation
[50]. Similar to cortical thickness, surface area is highly
heritable [11], yet has received less attention in human
imaging research. In this study, larger surface area was
found in patients with BD relative to MDD and healthy
controls. According to the tension-based theory of mor-
phogenesis [51], it is speculated that surface area expan-
sion might be indirectly associated with white matter
tracts damage, as more tension from white matter fibers
shrinkage could lead to deeper sulci and extended cor-
tical surface area. Therefore, the expansion of surface
area observed in our BD sample may suggest damages of
white matter tracts in the temporo-parietal regions,
which deserves further investigation using diffusion ten-
sor images. This speculation is supported by a recent
meta-analytical study showing that relative to patients
with MDD, BD patients had a greater reduction in frac-
tional anisotropy (FA) in the left posterior cingulum
[52]. Taken together, our findings suggest that volumet-
ric alterations reported in BD patients [18] might be the
result of variations in the surface area, while cortical
thickness may play a more important role in MDD pa-
tients [18, 19, 53]. Variations of brain volume in healthy
adults [54] and other psychiatric conditions, such as aut-
ism [12, 55], are driven predominately by differences in
cortical thickness or surface area. Variability in cortical
thickness and surface area in patients with BD and
MDD may thus reflect different underlying neuropatho-
logical underpinnings in the development of the
disorders.
Intriguingly, larger volumes of subcortical regions in-
volved in the mesocorticolimbic pathways were found in
patients with BD as compared to MDD, after controlling
for age, IQ estimate and intracranial volumes. When
compared to healthy controls, patients with MDD re-
vealed reduced volumes in the caudate, nucleus accum-
bens, hippocampus and amygdala [49]. Reduced neural
responses to rewards in these regions have also been re-
ported [56]. However, in contrast to the blunted striatal
signaling in MDD, elevated ventral striatal, orbitofrontal
and ventrolateral prefrontal activities during reward an-
ticipation have been observed in patients with BD [8, 9].
Therefore, the larger volumes of these dopamine-rich re-
gions we found in BD patients may provide additional
evidence to the emerging reward hypersensitivity theory
in BD.
By applying SVM discriminating classification on these
ROI morphological features, we were able to distinguish
between BD and MDD patients with up to 74.3 % cor-
rect classification rate. Different from the whole brain
classification approaches [29–31], in the present study,
we subsequently reduced the feature parameters by
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selecting a subset of ROIs that best distinguished be-
tween BD and MDD. In a relatively small sample, this
noise-reduction approach allows loading high weights
on the significant features (i.e., ROIs), resulting in an in-
crease of diagnostic accuracy. It is of note that, in our
sample, six patients with BD were misclassified as MDD
(sensitivity, 62.5 %) and three patients with MDD were
misclassified as BD (specificity, 84.3 %). This pattern is
in line with recent findings [57, 58] and the clinical com-
plexities in diagnosing BD from MDD. Patients with on-
set of depressive episodes are often diagnosed and
treated as having MDD until a manic or hypomanic epi-
sode emerges. The consequence of misdiagnosis could
lead to poor clinical outcomes resulting from ineffective
pharmacological treatments and delaying the course of
illness. More importantly, studies have reported an asso-
ciation between antidepressants and an elevated risk of
hypomanic, mania and rapid cycling [59]. The treat-
ments for MDD in BD patients may thus likely induce
the risk and frequency of manic/hypomanic episodes.
Therefore, accurately diagnosing BD and MDD has sig-
nificant therapeutic and prognostic importance. Current
clinical practice that relies solely on symptomatology in
making diagnosis renders relatively low sensitivity (BD:
45 %; MDD: 40 %) and specificity (BD: 81 %; MDD:
87 %) [60, 61]. The application of imaging-aided classifi-
cation approach may therefore help to improve accuracy
in diagnostic decisions for targeted treatment.
We acknowledged three limitations in this study.
Firstly, the possible medication effects on brain morpho-
logical alterations could not be estimated in this study.
The neurotropic effect of antidepressants on brain ana-
tomical changes has previously been reported [62]. In
addition, multiple recurrent episodes and chronicity of
conditions in BD and MDD may impact on the observed
morphometric abnormalities. Further investigations on
these disorder-related parameters, such as medication
and the number of recurrent episodes, are therefore war-
ranted. Secondly, the subtypes of BD were not examined
separately in this study due to the small sample size.
BD-II is generally considered as a milder form of manic-
depressive disorder from its less severe symptom inten-
sity, yet it was reported to be more severe in terms of its
episode frequency [63]. The clinical differences between
BD-I, BD-II and BD-NOS may likely suggest potential
biological differences. Thirdly, the relatively small sam-
ple size may potentially lend to Type I errors in the
SVM classification. Therefore, specific patterns we re-
ported must be considered as preliminary. Applying ma-
chine learning techniques to replicate neuroanatomical
models across samples in a larger scale is warranted. In
addition, in view of the explorative nature of this study,
permutation statistical control for multiple comparisons
was not carried out for the initial whole brain analyses
(see similar [45]). The resulting clusters from the whole
brain analyses in this study are considered robust as in-
dicative by the large number of significant vertices.
Moreover, the clusters defined as ROIs for subsequent
analyses reached a stringent significant threshold of
0.001, approximately equivalent to a p < 0.05 corrected
for multiple comparisons, when a priori hypothesis was
present [64]. Taken together, replication studies to examine
cortical thickness and surface area by separating subtypes
of BD in a larger sample would be beneficial to elucidate
the underlying neurobiological differences between BD
and MDD, which is a part of our on-going work.
Conclusions
We observed distinct spatially distributed variations in
cortical thickness and surface area in patients with BD
and MDD. Potentially, these findings may reflect neuro-
pathological processes of the two disorders, implying
that the two disorders may vary etiologically. Our
finding supports separating the two disorders into dif-
ferent clinical entities, despite some similar affective
symptoms are shared in common. Finally, this study
has shed light to the adoption of a multimodal classifi-
cation on disorder-specific biological features to aid
diagnostic decisions with significant therapeutic and
prognostic implications.
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